XML 19 R6.htm IDEA: XBRL DOCUMENT v3.26.1
Condensed Consolidated Statements of Cash Flows (Unaudited) - USD ($)
 9 Months Ended
Mar. 31, 2026
Mar. 31, 2025
Cash flows from operating activities:    
Net loss $ (16,404,698) $ (7,817,202)
Adjustments to reconcile net loss to net cash used in operating activities:    
Depreciation and amortization 3,717,691 3,356,752
Interest from amortization of loan issuance costs 90,124 161,905
Amortization of fair value of loan 90,321 0
Loss on extinguishment of debt 506,280 418,502
Change in fair value of warrant liability (0) (870,554)
Business Combination, Contingent Consideration, Change in Contingent Consideration, Liability, Increase (Decrease) 12,234,529 130,445
Loss on disposal of property and equipment 4,016 80,505
Stock-based compensation on stock options, RSUs & RSAs, net 1,261,577 745,155
Provision for credit losses (26,034) (3,014)
Change in operating lease assets and liabilities (181,814) (91,582)
Inventory write-offs to allowance 215,129 135,625
Deferred taxes (64,323) (2,368)
Changes in operating assets and liabilities, net of acquisitions:    
Trade accounts receivable (1,200,965) (822,043)
Other current assets (145,353) 73,362
Inventories (247,597) (1,206,340)
Prepaid expenses and deposits (2,182,257) (360,439)
Accounts payable and accrued liabilities 1,030,382 389,844
Net cash used in operating activities (5,116,579) (5,681,447)
Cash flows from investing activities:    
Purchase of property and equipment (1,844,395) (580,726)
Proceeds from sale of equipment 0 10,648
Net cash used in investing activities (8,844,506) (20,820,089)
Cash flows from financing activities:    
Proceeds from exercise of stock options 12,503 3,175
Proceeds from sale of common stock from Employee Stock Purchase Plan 24,862 14,385
Proceeds from issuance of common stock under public equity placement, net of fees 65,242,541 0
Proceeds from issuance of common stock under private equity placement, net of fees 7,894,045 437,725
Proceeds from issuance of preferred stock under private equity placement, net of fees 0 18,842,138
Proceeds from issuance of warrants under private equity placement, net of fees 0 4,620,561
Borrowings on loans payable 0 6,659,596
Loan issuance costs 0 (597,465)
Payments on loans payable (5,442,930) (149,118)
Repayment of finance lease obligations (168,089) (133,711)
Net cash provided by financing activities 64,026,461 29,572,286
Effect of exchange rate on cash and cash equivalents 292,769 (72,133)
Change in cash and cash equivalents 50,358,145 2,998,617
Cash and cash equivalents, beginning of period 4,877,036 3,480,268
Cash and cash equivalents, end of period 55,235,181 6,478,885
Supplemental disclosure of cash flow information:    
Interest paid in cash 390,457 66,136
Income taxes paid 194,527 118,016
Supplemental disclosure of non-cash investing & financing activities:    
Purchase of equipment through finance lease arrangements 275,471 93,048
Operating right-of-use assets acquired in exchange for operating lease liabilities 1,956,911 0
Conversion of Debt into Common Stock, Preferred Stock, Warrants, and a Note [Member]    
Supplemental disclosure of non-cash investing & financing activities:    
Extinguishment of debt in exchange for common stock, preferred stock, warrants and a note 0 3,057,110
G5 Infrared [Member]    
Adjustments to reconcile net loss to net cash used in operating activities:    
Earnout payment for acquisition of G5, net of financing portion (3,813,587) 0
Cash flows from investing activities:    
Acquisition 0 (20,250,011)
Cash flows from financing activities:    
Earnout payment for acquisition of G5, net of operating portion (3,536,471) 0
Supplemental disclosure of non-cash investing & financing activities:    
Issuance of common stock for acquisition 3,149,942 4,872,068
Accrual of earnout consideration 0 3,536,471
Amorphous Materials, LLC (“AML”) [Member]    
Cash flows from investing activities:    
Acquisition (7,000,111) 0
Supplemental disclosure of non-cash investing & financing activities:    
Issuance of common stock for acquisition 1,027,080 0
Accrual of earnout consideration 1,780,000 0
Visimid Technologies [Member]    
Cash flows from financing activities:    
Earnout payment for acquisition of G5, net of operating portion 0 (125,000)
Supplemental disclosure of non-cash investing & financing activities:    
Issuance of common stock for acquisition $ 350,000 $ 713,946